Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Boston, Massachusetts 02114


The purpose of this study is to see if using Cranial Electrical Stimulation (CES) helps improve symptoms of major depressive disorder (MDD). The investigators are studying the device's effectiveness in treating depression, as well as its safety. This is a pilot study. Eligible participants will be randomly assigned to receive either active CES or sham CES, every weekday for 3 weeks. During the visits, subjects will receive CES or sham CES treatment for 20 minutes. The primary outcome measure will be change in score on the HAM-D 17. The secondary outcome measure will be change in patient-reported sleep score.


Inclusion Criteria Subjects must meet all of the following criteria to participate in the study: 1. Age 18-65 years old 2. Be in generally good health 3. Meet criteria for Major Depressive Disorder based on the DSM-IV 4. HAM-D-17 score ≥ 15, and ≤ 23 Exclusion Criteria Subjects meeting any of the following criteria will not be allowed to participate in the study: 1. Taking any antidepressant medications (including natural products such as omega-3, St John's wort, and/or SAMe) 2. Having any unstable health conditions (unstable cardiovascular illness, cardiac arrhythmia, presence of a pacemaker, epilepsy and shock, fever, weakness and hypotension, or presence of a vagal nerve stimulator) 3. Having any electrical stimulation implants - i.e. pacemaker, deep brain stimulators (VNS, DBS), transcutaneous electrical nerve stimulator (TENS) 4. Psychotic or manic symptoms, or other evidence of a psychotic disorder; recent history of substance abuse or dependence 5. Electro Convulsive Therapy (ECT) during the last year 6. Previous course of Cranial Electrical Stimulation 7. Current active suicidal or self-injurious potential necessitating immediate treatment 8. In women, pregnancy, plans to conceive, or unwillingness to comply with birth control requirements 9. Depression-focused psychotherapy initiated within 90 days preceding enrollment or during participation in study



Primary Contact:

Principal Investigator
David Mischoulon, MD, PhD
Massachusetts General Hospital

Backup Contact:


Location Contact:

Boston, Massachusetts 02114
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.